Financial statements Theravibe
Balance sheet data of THERAVIBE
|
Year
|
2016
|
2018
|
2019
|
2020
|
2021
|
|---|---|---|---|---|---|
| Total assets | 238 471,16 | 176 028,13 | 173 712,62 | 163 855,36 | 162 411,80 |
| A. Fixed assets | 0,00 | 2 970,32 | 2 970,32 | 2 970,32 | 2 970,32 |
| B. Current assets | 238 471,16 | 173 057,81 | 170 742,30 | 160 885,04 | 159 441,48 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 238 471,16 | 176 028,13 | 173 712,62 | 163 855,36 | 162 411,80 |
| A. Equity | -1 383,98 | -5 570,22 | 18 045,18 | 14 395,87 | 12 952,31 |
| B. Liabilities and provisions for liabilities | 239 855,14 | 181 598,35 | 155 667,44 | 149 459,49 | 149 459,49 |
| I. Long-term liabilities | 61 430,00 | 113 157,22 | 136 939,17 | 136 939,17 | 136 939,17 |
| II. Short-term liabilities | 5 005,59 | 29 561,95 | 18 728,27 | 12 520,32 | 12 520,32 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.